Tenaya Therapeutics's market cap is currently $90.31M. The company's EPS TTM is $-1.477; its P/E ratio is ―; Tenaya Therapeutics is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -8.69M	$ -8.71M	$ -4.03M	$ -2.48M	$ -1.99M
Operating Income	$ -131.19M	$ -125.62M	$ -72.81M	$ -38.91M	$ -27.71M
EBITDA	$ -122.51M	$ -114.95M	$ -68.70M	$ -36.43M	$ -25.72M
Net Income	$ -124.08M	$ -123.66M	$ -69.65M	$ -38.31M	$ -25.78M
Balance Sheet
Cash & Short-Term Investments	$ 104.64M	$ 204.23M	$ 251.30M	$ 128.53M	$ 26.63M
Total Assets	$ 170.51M	$ 278.94M	$ 314.19M	$ 148.16M	$ 38.00M
Total Debt	$ 12.42M	$ 15.10M	$ 13.71M	$ 0.00	$ 0.00
Net Debt	$ -33.26M	$ -80.17M	$ -24.42M	$ -128.53M	$ -23.87M
Total Liabilities	$ 31.09M	$ 278.94M	$ 35.66M	$ 229.48M	$ 81.74M
Stockholders' Equity	$ 139.42M	$ 243.38M	$ 278.53M	$ -81.31M	$ -43.74M
Cash Flow
Free Cash Flow	$ -103.31M	$ -125.05M	$ -85.93M	$ -45.21M	$ -27.02M
Operating Cash Flow	$ -102.07M	$ -104.42M	$ -60.81M	$ -35.45M	$ -24.10M
Investing Cash Flow	$ 48.72M	$ 83.65M	$ -238.56M	$ -7.01M	$ -5.58M
Financing Cash Flow	$ 4.05M	$ 77.77M	$ 208.97M	$ 147.27M	$ 30.51M

Currency in USD

Tenaya Therapeutics Earnings and Revenue History

Income Statement >

Tenaya Therapeutics Debt to Assets

Balance Sheet >

Tenaya Therapeutics Cash Flow

Cash Flow >

Tenaya Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing